{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-014518","form_type":"8-K","ticker":"BLGO","cik":"0000880242","company_name":"BIOLARGO, INC.","filed_at":"2022-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.084084+00:00","generated_at":"2026-06-25T04:09:01.978675+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioLargo shareholders approve increase in authorized shares to 550M and authorize reverse stock split","bullets":["Authorized common shares increased from 400M to 550M, effective June 7, 2022.","Board authorized to implement a reverse stock split at a ratio between 1:4 and 1:25 at its discretion.","All seven director nominees elected; advisory say-on-pay passed with 84.3M for, 9.8M against.","Ratification of Haskell & White LLP as auditor for FY2022 approved with 151.2M for.","Reverse split proposal passed with 136.2M for, 16.7M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-014518","json":"https://secwatch.observer/filing/0001437749-22-014518.json","markdown":"https://secwatch.observer/filing/0001437749-22-014518.md","text":"https://secwatch.observer/filing/0001437749-22-014518.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880242/000143774922014518/0001437749-22-014518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880242/000143774922014518/blgo20220606_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:09:01.978675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}